Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase 2 Study of the Safety and Efficacy of Neoadjuvant Botensilimab in Combination With Balstilimab in the Treatment of Microsatellite Stable / Mismatch Repair Proficient Early Rectal Cancer (RECTIFY-1)
This is a multi-site, prospective, non-randomized phase 2 study evaluating neoadjuvant botensilimab in combination with balstilimab for patients with microsate…
Early Rectal CancerStage I Rectal CancerMicrosatellite Stable Rectal Carcinoma
Estimated
~$10 – $7,500
Dana-Farber Cancer InstituteNCT07735624
Phase 2
A Phase II Study of Neoadjuvant Botensilimab and Balstilimab Immunotherapy for Mismatch Repair Proficient Rectal Adenocarcinoma
The purpose of this study is to find out whether the combination of botensilimab and balstilimab (BOT/BAL) is a safe and effective treatment that causes few or…
Microsatellite Stable Rectal CarcinomaLocally Advanced Rectal Adenocarcinoma
Estimated
~$10 – $6,250
Memorial Sloan Kettering Cancer CenterNCT06843434